Sjoerd Lagarde

Sjoerd Lagarde is a researcher in the Department of Surgery at Erasmus MC, a leading academic medical center in the Netherlands. He is actively engaged in clinical and translational research in surgical oncology, particularly focusing on esophageal and gastric cancers. His work is frequently published in high-impact journals and involves major international collaborations.

Research Interests: Dr. Lagarde's research centers on improving outcomes for patients with upper gastrointestinal cancers. His primary interests include neoadjuvant chemoradiotherapy, active surveillance strategies, surgical techniques like esophagectomy and gastrectomy, and long-term survival analysis. He is deeply involved in landmark clinical trials such as the SANO trial and the IVORY study, which aim to redefine treatment paradigms in esophageal cancer.

Publication Trends: His recent articles reflect a strong focus on comparative effectiveness, treatment innovation, and clinical decision-making in oncologic surgery. Themes include non-surgical management of esophageal cancer, postoperative complications, and international variations in surgical practice. The integration of large-scale audit data and randomized trial evidence underscores his methodological rigor.

Scientific Contributions:

• Key contributor to the SANO phase 3 trial on active surveillance after chemoradiotherapy.
• Active participant in multicenter studies assessing surgical outcomes in gastrectomy and esophagectomy.
• Member of major research consortia including the SANO study group and IVORY study group.

Advising and Grants: While specific students are not listed, his involvement in supervised work (4 items) suggests a mentoring role. He likely contributes to grant-funded research through collaborative networks and clinical trial consortia, though specific grants are not mentioned in the text.

Labs and Teams: Dr. Lagarde works within the surgical oncology research team at Erasmus MC and collaborates extensively with national and international audit databases and clinical research groups. His work is embedded in large-scale collaborative networks such as the GastroBenchmark Consortium and GASTRODATA Consortium, indicating a team-based, data-driven research approach.